Effects of Non-Steroidal Mineralocorticoid Antagonist (Finerenone) in Western Diet-Induced Kidney Disease

被引：0
|
作者：
Myakala, Komuraiah [1 ]
Ribeiro, Patricia de Carvalho [1 ]
Wang, Xiaoxin [1 ]
Korolowicz, Kyle E. [1 ]
Rodriguez, Olga C. [1 ]
Albanese, Chris [1 ]
Levi, Moshe [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO242
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [31] Non-steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes
    Solis-Herrera, Carolina
    Triplitt, Curtis
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 417 - 430
  • [32] Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Kintscher, Ulrich
    Bakris, George L.
    Kolkhof, Peter
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3220 - 3234
  • [33] Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease
    Akshyaya Pradhan
    Umesh Chandra Tripathi
    The Egyptian Heart Journal, 76 (1)
  • [34] Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
    Jerome, Jack R.
    Deliyanti, Devy
    Suphapimol, Varaporn
    Kolkhof, Peter
    Wilkinson-Berka, Jennifer L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [35] Benefit of the non-steroidal mineralocorticoid receptor antagonist BR-4628 in renal injury induced by ischemia/reperfusion
    Barrera-Chimal, JJonatan
    Prince, S.
    El Moghrabi, S.
    Kolkhof, P.
    Fadel, F.
    Jaisser, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 108 - 108
  • [36] Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease
    Bramlage, Peter
    Swift, Stephanie L.
    Thoenes, Martin
    Minguet, Joan
    Ferrero, Carmen
    Schmieder, Roland E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (01) : 28 - 37
  • [37] Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease
    Rahman, Asadur
    Jahan, Nourin
    Rahman, Md Tanvir
    Nishiyama, Akira
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [38] The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
    Xinping Chen
    Xuan Li
    Kexin Zhang
    Kexin Lian
    Wenqiang Zhang
    Yixin Song
    Chengxia Kan
    Jingwen Zhang
    Fang Han
    Xiaodong Sun
    Zhentao Guo
    Clinical and Experimental Nephrology, 2024, 28 : 125 - 135
  • [39] Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes
    Lerma, Edgar V.
    Wilson, Daniel J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (05) : 501 - 513
  • [40] The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
    Chen, Xinping
    Li, Xuan
    Zhang, Kexin
    Lian, Kexin
    Zhang, Wenqiang
    Song, Yixin
    Kan, Chengxia
    Zhang, Jingwen
    Han, Fang
    Sun, Xiaodong
    Guo, Zhentao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 28 (2) : 125 - 135
12345